Rakesh Popat MBBS, MRCP, FRCPath, PhD

Dr. Rakesh Popat is an Associate Professor at University College London and a Consultant Hematologist at University College London Hospitals with an interest in multiple myeloma. He graduated from Guy’s and St. Thomas’ Medical School in London and trained in hematology at St. Bartholomew’s and the Royal London Hospitals. During this time he completed a PhD in novel treatments for myeloma and was awarded a fellowship to attend the Dana Farber Cancer Institute, in Boston, USA.

He is particularly experienced in novel treatments including immunotherapies such as CAR-T cell therapy and new antibody approaches. At University College Hospital, he leads the myeloma clinical trials program and is the cancer lead for early-phase clinical trials at the NIHR UCLH Clinical Research Facility.

Dr Popat is the Chair of the UK Myeloma Research Alliance, NCRI Myeloma working group is on the executive board of the UK Myeloma Forum, and the young board of the European Myeloma Network. He is the Chief Investigator for a number of relapsed myeloma studies and the Principal Investigator for the NIHR Health Informatics Collaborative Myeloma Theme.